This study demonstrates that centralised governance, combined with georeferenced vaccination data, environmental poliovirus surveillance, and clinical AFP surveillance, enhances the ability to identify coverage gaps and respond to infectious disease threats. This evidence concerns the gene AFP and infectious disease.